Acorda Therapeutics (ACORQ) SEC Filings & 10K Form

$0.60
+0.09 (+17.65%)
(As of 12:42 PM ET)

Recent Acorda Therapeutics SEC Filings

DateFilerForm TypeView
05/14/2024
7:24 AM
Acorda Therapeutics, Inc. (Filer)
Acorda Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
7:39 AM
Acorda Therapeutics, Inc. (Filer)
Acorda Therapeutics (Filer)
Form 10-K/A
04/25/2024
7:00 PM
Acorda Therapeutics, Inc. (Filer)
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
8:10 AM
Acorda Therapeutics, Inc. (Subject)
Acorda Therapeutics (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
04/17/2024
8:10 AM
Acorda Therapeutics, Inc. (Filer)
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
3:30 PM
Acorda Therapeutics, Inc. (Filer)
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2024
7:33 AM
Acorda Therapeutics, Inc. (Filer)
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2023
3:30 PM
Acorda Therapeutics, Inc. (Filer)
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2023
3:35 PM
Acorda Therapeutics, Inc. (Filer)
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2023
3:30 PM
Acorda Therapeutics, Inc. (Filer)
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2023
6:57 PM
Acorda Therapeutics, Inc. (Issuer)
Acorda Therapeutics (Issuer)
BURNS THOMAS M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/23/2023
6:59 PM
Acorda Therapeutics, Inc. (Issuer)
Acorda Therapeutics (Issuer)
BURNS THOMAS M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
4:34 PM
Acorda Therapeutics, Inc. (Issuer)
Acorda Therapeutics (Issuer)
Jensen Peder (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
4:36 PM
Acorda Therapeutics, Inc. (Issuer)
Acorda Therapeutics (Issuer)
Kelley John P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
4:37 PM
Acorda Therapeutics, Inc. (Issuer)
Acorda Therapeutics (Issuer)
PANEM SANDRA PHD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
4:38 PM
Acorda Therapeutics, Inc. (Issuer)
Acorda Therapeutics (Issuer)
Varian John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2023
4:17 PM
Acorda Therapeutics, Inc. (Filer)
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ACORQ) was last updated on 5/17/2024 by MarketBeat.com Staff

From Our Partners